Docoh
Loading...

FGEN FibroGen

GRANT
Utility
Enhanced erythropoiesis and iron metabolism
23 Feb 21
The present invention relates to methods and compounds for regulating or enhancing erthropoiesis and iron metabolism, and for treating or preventing iron deficiency and anemia of chronic disease.
Stephen J Klaus, Al Y. Lin, Thomas B. Neff, Volkmar Guenzler-Pukall, Qingjian Wang, Lee A. Flippin, Michael P. Arend
Filed: 30 Jan 18
GRANT
Utility
Enhanced erythropoiesis and iron metabolism
19 Jan 21
The present invention relates to methods and compounds for regulating or enhancing erthropoiesis and iron metabolism, and for treating or preventing iron deficiency and anemia of chronic disease.
Stephen J. Klaus, Christopher J Molineaux, Thomas B Neff, Volkmar Guenzler-Pukall, Robert C. Stephenson, Todd W. Seeley, Ingrid Langsetmo Parobok
Filed: 27 Apr 17
GRANT
Utility
Enhanced erythropoiesis and iron metabolism
4 Jan 21
The present invention relates to methods and compounds for regulating or enhancing erythropoiesis and iron metabolism, and for treating or preventing iron deficiency and anemia of chronic disease.
Stephen J Klaus, Christopher J Molineaux, Thomas B Neff, Volkmar Guenzler-Pukall, Robert C Stephenson, Todd W Seeley, Ingrid Langsetmo Parobok
Filed: 28 Jan 18
APP
Utility
Methods of Treatment of Muscular Dystrophies
25 Nov 20
The invention relates to methods and agents useful for treating muscular dystrophies (MDs), in particular, Duchenne muscular dystrophy (DMD).
Kin-Hung (Peony) YU, Elias KOUCHAKJI, Bassem ELMANKABADI, Tro SEKAYAN
Filed: 20 May 20
GRANT
Utility
Pharmaceutical formulations of a HIF hydroxylase inhibitor
7 Sep 20
The present disclosure relates to pharmaceutical formulations of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid and methods of use thereof.
David Conca, Lee Allen Flippin, Scott David Leigh, Claudia Witschi, Lee Robert Wright
Filed: 12 Jul 18
GRANT
Utility
Nitrogen-containing heteroaryl compounds and methods of use thereof
11 May 20
The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.
Michael P. Arend, Lee A. Flippin, Volkmar Guenzler-Pukall, Wen-Bin Ho, Eric D. Turtle, Xiaohui Du
Filed: 21 Aug 18
GRANT
Utility
Enhanced erythropoiesis and iron metabolism
20 Apr 20
The present invention relates to methods and compounds for regulating or enhancing ethropoiesis and iron metabolism, and for treating or preventing iron deficiency and anemia of chronic disease.
Stephen J. Klaus, Christopher J Molineaux, Thomas B Neff, Volkmar Guenzler-Pukall, Robert C. Stephenson, Todd W. Seeley, Ingrid Langsetmo Parobok
Filed: 16 Apr 17
APP
Utility
Methods for Treating Idiopathic Pulmonary Fibrosis
15 Apr 20
The present invention relates to methods and medicaments useful for treating idiopathic pulmonary fibrosis (IPF) by administering anti-CTGF antibodies.
Seth PORTER, John L. Stauffer
Filed: 10 Dec 19
APP
Utility
Crystalline Forms of a Prolyl Hydroxylase Inhibitor
15 Apr 20
The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.
Claudia Witschi, Jung Min Park, Michael D. Thompson, Michael John Martinelli, David A. Yeowell, Michael P. Arend
Filed: 15 Dec 19
GRANT
Utility
Methods for treating idiopathic pulmonary fibrosis
10 Feb 20
The present invention relates to methods and medicaments useful for treating idiopathic pulmonary fibrosis (IPF) by administering anti-CTGF antibodies.
Seth Porter, John L. Stauffer
Filed: 4 Jul 18
  • 1
Patents are sorted by USPTO publication date, most recent first